explore -WSS

explore

author：knowledge 2025-10-01 18:45:40 - browse：5

The removal of small amounts of brain tissue from desperately ill patients, done as part of a Mount Sinai research project, triggered alarm bells at the Food and Drug Administration and has raised broader questions about the scientific and ethical justification for live-brain research. Journalist and STAT contributor Katherine Eban joins “The Readout LOUD” podcast to discuss the results of a two-year investigation.

Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo Nordisk’s blockbuster obesity drugs with Elaine Chen, the newest member of STAT’s biotech reporting team.

For more on what we cover, here’s STAT’s investigation into the Mount Sinai brain-tissue research project; here’s exclusive reporting on the MorphoSys drug at the center of the Novartis acquisition, and Adam Feuerstein’s take on where it might run off the rails; and here’s STAT’s reporting on Novo Nordisk and its weight loss drug Wegovy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Beam Therapeutics to lay off 20% of its staff, re

WSS

2023 STAT Wunderkinds: get to know the winners

The EU Joint Clinical Assessment needs to live up to its promise

2023 STAT Wunderkinds: get to know the winners

2023 STAT Wunderkinds: get to know the winners

Novo Nordisk obesity pill bests Wegovy in early trial

Researchers explore possible ties between long Covid, menopause

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Walensky prepares to leave CDC — and Congress — behind

Why health workers in Gaza are injured or die at high rates

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

STAT Summit: How a Chicago ER doctor tackles gun violence

Bright Health sells Medicare Advantage business to Molina

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Psychedelics group wrestles with new pharma identity

Hospital price transparency does save money, advocate argues

Continuity nursing helped my family in our darkest PICU moments

The drug industry has found itself all alone in Washington

hotspot

Sen. Paul opposes bill to ban Chinese biotechs

The EU Joint Clinical Assessment needs to live up to its promise

Amylyx ALS drug failure raises questions and concerns

Headspace, Meta partner to launch VR meditation app for Quest

Researchers explore possible ties between long Covid, menopause

How to bring more disabled researchers into academia

Wikipedia

entertainment

explore

hotspot